These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21966412)

  • 1. Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function.
    Liao WW; Arthur JW
    PLoS One; 2011; 6(9):e25055. PubMed ID: 21966412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models.
    Mamitsuka H
    Proteins; 1998 Dec; 33(4):460-74. PubMed ID: 9849933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
    Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
    Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosis.
    McMahon RM; Friis L; Siebold C; Friese MA; Fugger L; Jones EY
    Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):447-54. PubMed ID: 21543847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.
    Scholz E; Mestre-Ferrer A; Daura X; García-Medel N; Carrascal M; James EA; Kwok WW; Canals F; Álvarez I
    Arthritis Rheumatol; 2016 Oct; 68(10):2412-21. PubMed ID: 27158783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
    Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
    PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
    Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
    J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen.
    Li H; Zhao Y; Guo Y; Li Z; Eisele L; Mourad W
    J Biol Chem; 2007 Mar; 282(9):5991-6000. PubMed ID: 17166841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a structural homology model for a class II histocompatibility protein, HLA-DR1: comparison to the crystal structure.
    Nauss JL; Reid RH; Sadegh-Nasseri S
    J Biomol Struct Dyn; 1995 Jun; 12(6):1213-33. PubMed ID: 7669268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles.
    Muixí L; Gay M; Muñoz-Torres PM; Guitart C; Cedano J; Abian J; Alvarez I; Jaraquemada D
    Genes Immun; 2011 Oct; 12(7):504-12. PubMed ID: 21654843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.